{"id":403944,"date":"2020-12-21T14:13:09","date_gmt":"2020-12-21T19:13:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=403944"},"modified":"2020-12-21T14:13:09","modified_gmt":"2020-12-21T19:13:09","slug":"biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/","title":{"rendered":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong>Mainz, Germany, December 21, 2020<\/strong><br \/>\n        <strong>(GLOBE NEWSWIRE)<\/strong> \u2013 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KStPOspB1h2PPJPFtWwnoopu6yVJe4nArZKiUqLnbv-vLrxpwAd6qnlICqyPL5PB3PGYT4D1759LbnKSQrSxMQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>BioNTech SE<\/u><\/a> (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will hold a press conference including a video webcast on Tuesday, December 22, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2. The event will be held virtual and in English:<\/p>\n<p>\n        <strong>International press conference at 09.00am CET \/ 03.00am ET<\/strong><br \/>\n        <br \/>Please register <strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Fc-09CsH63o0UM_c-u1zd1g8F47Qzcf-oD8qjC16OiA0s1PQOUfP1EDUgOyk6LmJQZ3L-JmEGoe08REHQvTUQzw_uBU8kfYNoSM9bTN0u9VXZ9xhiuatt5QPFtp1JcZYnumyEz1JCKPRBTLxhogQDEyKMX2yv_VlLmFno8VQgvYl7mjVeU8RFxaaCGbL392j\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>here<\/u><\/a><\/strong>.<\/p>\n<p align=\"justify\">Interested journalists may dial in 10-15 minutes before the conference starts. They will be able to submit questions via an online tool.\u00a0The press conference will be virtual only. <\/p>\n<p align=\"justify\">Participants may also access the press conference, including the video webcast, on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wiwF4Hu6XQStbBhht96FXOz0GUxXEtVIkK538995nc5egvYvGuhA3u_gQRc7E7ljfOByHEZWkEaT95wofLth8g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>https:\/\/biontech.de\/<\/u><\/a> under &#8220;Events &amp; Presentations&#8221; in the Investor &amp; Media section of the website. A recording of the press conference will be available on the same day. Additional media materials including images and videos can be accessed through the following link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-xupSEF61Be_k16rOgBCTvTnuKPk4irKXzO0sbUlm7AdgRh08GAA9TnTIgKN5YHaBzNrlJdlalc-stiuv8793MEsIxRYvs0aCRDElydL0qP2wZDJHmNwgkBva7p-mikOw2FpGYQ4uIV_zPJBCivAeA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>press kit<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About BioNTech<\/strong><br \/>\n        <br \/>Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. <\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v9wlyM5bYIjioIYyf1z8nb4wzEp-H1p7-BHfR-DZh-Tr41Ablg7TqxAAhqU37FQ5Ofa-dnOVRpo89uvqktt_pg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.BioNTech.de<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>BioNTech Contacts<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>Jasmina Alatovic<br \/>Director External Communications<br \/>+49 (0)89 62 81 75 46<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ah64YzPHidbe3mQgp1abqQDkc0g-MeibvXXllOL_Dn2KURJyWO3v16W4ZbTUVG5WTRdXaIHsSYedOw-XnErmanQpe11dsP7KNiK26RyBYZY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Media@biontech.de<\/u><\/a><\/p>\n<p align=\"justify\">\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Sylke Maas, Ph.D. <br \/>VP Investor Relations &amp; Business Strategy<br \/>+49 (0)6131 9084 1074<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1QqKPvtClcUhSPzfhbT3Lq4w5j8VTlj9Phqpo0PFG7AJofPdgjLpBKs90AI_88ybkg_BYVKH9eXbNe_0iJd5aEaaikV-5lD8ldb-0dg81ss=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Investors@biontech.de<\/u><\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/8e979e13-e061-4e98-9523-fddb3b2c5de0\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Mainz, Germany, December 21, 2020 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will hold a press conference including a video webcast on Tuesday, December 22, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2. The event will be held virtual and in English: International press conference at 09.00am CET \/ 03.00am ET Please register here. Interested journalists may dial in 10-15 minutes before the conference starts. They will be able to submit questions via an online tool.\u00a0The press conference will be virtual only. Participants may also access the press conference, including the video webcast, on https:\/\/biontech.de\/ under &#8220;Events &amp; Presentations&#8221; in the Investor &amp; Media &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-403944","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Mainz, Germany, December 21, 2020 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will hold a press conference including a video webcast on Tuesday, December 22, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2. The event will be held virtual and in English: International press conference at 09.00am CET \/ 03.00am ET Please register here. Interested journalists may dial in 10-15 minutes before the conference starts. They will be able to submit questions via an online tool.\u00a0The press conference will be virtual only. Participants may also access the press conference, including the video webcast, on https:\/\/biontech.de\/ under &#8220;Events &amp; Presentations&#8221; in the Investor &amp; Media &hellip; Continue reading &quot;BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-21T19:13:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program\",\"datePublished\":\"2020-12-21T19:13:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/\"},\"wordCount\":333,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/\",\"name\":\"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==\",\"datePublished\":\"2020-12-21T19:13:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/","og_locale":"en_US","og_type":"article","og_title":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk","og_description":"Mainz, Germany, December 21, 2020 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will hold a press conference including a video webcast on Tuesday, December 22, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2. The event will be held virtual and in English: International press conference at 09.00am CET \/ 03.00am ET Please register here. Interested journalists may dial in 10-15 minutes before the conference starts. They will be able to submit questions via an online tool.\u00a0The press conference will be virtual only. Participants may also access the press conference, including the video webcast, on https:\/\/biontech.de\/ under &#8220;Events &amp; Presentations&#8221; in the Investor &amp; Media &hellip; Continue reading \"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-21T19:13:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program","datePublished":"2020-12-21T19:13:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/"},"wordCount":333,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/","name":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==","datePublished":"2020-12-21T19:13:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0NzI0MyM0MDA4NDIwNDgjMjAwMDk4NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=403944"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/403944\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=403944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=403944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=403944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}